Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Targeted Therapies in Oncology, Second Edition
Since the last edition of this book, major advances have been made in our understanding of key pathways that control tumor progression. This has led to the development of new anticancer agents that have the ability to block the activity of proteins involved in neoplastic cell development and proliferation. Targeted Therapies in Oncology, Second Edition provides a concise timely panorama of existing targeted therapies and progress into future anticancer treatments. These therapies notably include: Targeted agents of immune checkpoints Signal-transduction inhibitors Antiangiogenic agents Vascular-disrupting agents Apoptosis modulators Stem cell inhibitors Tumor profiling for drug development The book emphasizes the biology behind this new class of drugs as well as the clinical achievements obtained. The contributors to this volume stand at the cutting edge of cancer research and treatment around the world.
Hospital Medicine
Now thoroughly updated, this resource offers practical, evidence-based guidelines for the care of hospitalized patients. The only book geared directly and exclusively to inpatient management, this guide is edited by national leaders in the hospital field.
Having Children After Cancer
Yes, you can have children after cancer. When faced with a cancer diagnosis, many doctors and patients rush full-speed ahead into treatment, giving minimal attention to the potential fertility implications. Luckily, the field of oncofertility is growing quickly, and medical writer Gina Shaw, herself a cancer survivor, is ready to unravel the complex and evolving issues involved in pre- and post-cancer fertility and family-building options—for both men and women. Having Children After Cancer gives you all the tools you need to: Understand how different cancers can affect fertility Identify which treatments―chemo, radiation, and surgery―can potentially impair your fertility Discuss ferti...
Cancer: Principles & Practice of Oncology
Announcing the second volume of DeVita, Lawrence and Rosenberg's groundbreaking series, Cancer: Principles & Practice of Oncology—Annual Advances in Oncology. This series of annual volumes focuses on the most significant changes in oncologic research and practice that have taken place during the preceding year. Each volume identifies scientific and clinical areas in oncology that are rapidly changing and show a high potential for affecting the management of cancer patients in the future. These areas may reflect current controversies in oncology and every effort is made to provide clear direction for the practicing oncologist.
Breast Disease
Breast Disease: Comprehensive Management provides a clear, concise source of information in order to make real-life, evidence-based decisions for all aspects of breast disease, both benign and malignant. The volume provides the latest breakthroughs in breast cancer research, ranging from paradigm shifts in the surgical management of the axilla, the changing role of adjuvant and neoadjuvant chemotherapy, the impact of molecular medicine in decision-making and the controversial role of prophylactic mastectomy in our era. Within select chapters, “How I do it” clinical scenarios are supplied and described in very practical terms. Also included at the end of each chapter are synoptic question...
Cancer Consult: Expertise in Clinical Practice, Volume 2
CANCER CONSULT New edition covering the specialties of hematology, oncology and cellular therapy, now in two volumes Cancer Consult: Expertise in Clinical Practice, Volume 2: Neoplastic Hematology & Cellular Therapy, Second Edition includes hundreds of answers to practice-based questions covering the new principles of diagnosis, classification, staging, treatment, and outcomes in the rapidly advancing field of cancer. This textbook series also provides expert guidance in the areas of cancer-related uncertainties and controversies, including experience-based discussions. The book’s smaller size allows for easy access during medical rounds. This volume also includes: Up-to-date clinically re...
The MASCC Textbook of Cancer Supportive Care and Survivorship
This book is intended for medical students, residents, and fellows, as well as medical oncologists, radiation oncologists, surgeons, general practitioners, nurses and allied health workers. Complete with case vignettes, key points, and sidebar summaries to further assist readers using practical tips and tricks, this textbook provides current information on the management and prevention of cancer-related side effects, referring to up-to-date sources that are useful for conducting further research. It also introduces new topics, such as financial toxicity and complementary medicine, as well as covering the new side effects of targeted therapies not covered in the last edition. Additionally, MA...
Everyone's Guide to Cancer Therapy
“Written by two oncologists . . . this authoritative but readable reference stands out . . . as a uniquely comprehensive, thorough source of up-to-date information” (Library Journal). For more than thirty years, Everyone’s Guide to Cancer Therapy has been the definitive resource for anyone confronting a cancer diagnosis. The revised and updated fifth edition draws on the latest research, information, and advice from more than 100 top oncology specialists. Equally informative and accessible, this comprehensive book helps cancer patients and their caregivers navigate through diagnosis, treatment, and supportive care. Topics include: * Information on recently approved targeted therapies for various cancer types * The newest strategies in cancer diagnosis and prevention * Cancer biology: translating scientific discoveries into meaningful advances for patients * Supportive care and complementary approaches
Cancer Drug Delivery Systems Based on the Tumor Microenvironment
This book proposes the importance of new systems of drug design and delivery based on cancer pathophysiology in addition to cancer molecular and cellular biology. The current studies based on molecular and cellular biology while ignoring pathophysiology and pharmacology may be leading the development of antitumor drugs in the wrong direction and wasting a lot of money. Although there have been numerous reports of genetic and phenotypic changes in tumors, a large body of pathological and clinical evidence supports the conclusion that there are no pivotal changes in tumor cells that distinguish them consistently and reliably from normal dividing cells. Unlike using antibiotics against bacteria...
